Allen S. Melemed - Jan 17, 2023 Form 4 Insider Report for CHIMERIX INC (CMRX)

Role: Chief Medical Officer
Signature: /s/ Michael Alrutz, Attorney-in-Fact
Stock symbol: CMRX
Transactions as of: Jan 17, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/19/2023, 08:47 PM
Previous filing: Jan 20, 2022
Next filing: Feb 2, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMRX	Common Stock	Award	$0	+25.7K	+116.22%	$0.00	47.9K	Jan 17, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMRX	Stock Option (Right to Buy)	Award	$0	+154K		$0.00	154K	Jan 17, 2023	Common Stock	154K	$1.97	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares being reported are being issued pursuant to restricted stock unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 6,435 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 6,435 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 6,435 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 6,435 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.
F2	Includes 4,345 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on March 10, 2021, 6,414 shares acquired under the ESPP on September 10, 2021, 6,707 shares acquired under the ESPP on March 10, 2022 and 4,681 shares acquired under the ESPP on September 9, 2022.
F3	1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.